Literature DB >> 28971976

Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.

David E Surate Solaligue1,2, José Alberto Rodríguez-Castillo1,2, Katrin Ahlbrecht1,2, Rory E Morty3,2.   

Abstract

The objective of lung development is to generate an organ of gas exchange that provides both a thin gas diffusion barrier and a large gas diffusion surface area, which concomitantly generates a steep gas diffusion concentration gradient. As such, the lung is perfectly structured to undertake the function of gas exchange: a large number of small alveoli provide extensive surface area within the limited volume of the lung, and a delicate alveolo-capillary barrier brings circulating blood into close proximity to the inspired air. Efficient movement of inspired air and circulating blood through the conducting airways and conducting vessels, respectively, generates steep oxygen and carbon dioxide concentration gradients across the alveolo-capillary barrier, providing ideal conditions for effective diffusion of both gases during breathing. The development of the gas exchange apparatus of the lung occurs during the second phase of lung development-namely, late lung development-which includes the canalicular, saccular, and alveolar stages of lung development. It is during these stages of lung development that preterm-born infants are delivered, when the lung is not yet competent for effective gas exchange. These infants may develop bronchopulmonary dysplasia (BPD), a syndrome complicated by disturbances to the development of the alveoli and the pulmonary vasculature. It is the objective of this review to update the reader about recent developments that further our understanding of the mechanisms of lung alveolarization and vascularization and the pathogenesis of BPD and other neonatal lung diseases that feature lung hypoplasia.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  BPD; CDH; alveolarization; hyperoxia; lung development; mechanical ventilation; pulmonary hypertension

Mesh:

Substances:

Year:  2017        PMID: 28971976     DOI: 10.1152/ajplung.00343.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  43 in total

1.  Stereological analysis of individual lung lobes during normal and aberrant mouse lung alveolarisation.

Authors:  Tuong-Van Hoang; Claudio Nardiello; David E Surate Solaligue; José Alberto Rodríguez-Castillo; Philipp Rath; Konstantin Mayer; István Vadász; Susanne Herold; Kathrin Ahlbrecht; Werner Seeger; Rory E Morty
Journal:  J Anat       Date:  2018-01-09       Impact factor: 2.610

2.  Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.

Authors:  Noah H Hillman; T Brett Kothe; Augusto F Schmidt; Matthew W Kemp; Emily Royse; Erin Fee; Fabrizio Salomone; Michael W Clarke; Gabrielle C Musk; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

3.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

Review 4.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

5.  Integrating multiomics longitudinal data to reconstruct networks underlying lung development.

Authors:  Jun Ding; Farida Ahangari; Celia R Espinoza; Divya Chhabra; Teodora Nicola; Xiting Yan; Charitharth V Lal; James S Hagood; Naftali Kaminski; Ziv Bar-Joseph; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-21       Impact factor: 5.464

6.  Hyperoxia Injury in the Developing Lung Is Mediated by Mesenchymal Expression of Wnt5A.

Authors:  Jennifer M S Sucre; Kasey C Vickers; John T Benjamin; Erin J Plosa; Christopher S Jetter; Alissa Cutrone; Meaghan Ransom; Zachary Anderson; Quanhu Sheng; Benjamin A Fensterheim; Namasivayam Ambalavanan; Bryan Millis; Ethan Lee; Andries Zijlstra; Melanie Königshoff; Timothy S Blackwell; Susan H Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

7.  Time-resolved proteome profiling of normal lung development.

Authors:  Ahmed Moghieb; Geremy Clair; Hugh D Mitchell; Joseph Kitzmiller; Erika M Zink; Young-Mo Kim; Vladislav Petyuk; Anil Shukla; Ronald J Moore; Thomas O Metz; James Carson; Jason E McDermott; Richard A Corley; Jeffrey A Whitsett; Charles Ansong
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-08       Impact factor: 5.464

8.  Intrauterine growth restriction decreases NF-κB signaling in fetal pulmonary artery endothelial cells of fetal sheep.

Authors:  R Blair Dodson; Kyle N Powers; Jason Gien; Paul J Rozance; Gregory Seedorf; David Astling; Kenneth Jones; Timothy M Crombleholme; Steven H Abman; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-03       Impact factor: 5.464

9.  Swapping mitochondria: a key to understanding susceptibility to neonatal chronic lung disease.

Authors:  Andrew M Dylag; Paul S Brookes; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-09       Impact factor: 5.464

Review 10.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.